Copy Number
The putative cancer-associated PDGs driven by SCNAs in each cancer type were identified by four criteria: 1) located in a peak region of a significantly recurrent focal SNCA locus estimated by the genomic identification of significant targets in cancer (GISTIC2) algorithm, (q≤0.25); 2) altered with high frequency and large amplitude (G-score ≥0.1); 3) mRNA reliably detected in at least 10% of tumor specimens in the given cancer type (90th percentile of FPKM value ≥1); and 4) mRNA significantly and positively correlated with copy numbers (Pearson P-value less than 0.001).
| Showing page 78 |
first page | previous page | next page | last page |
| Overall_Gscore | No. of Cancer Types | ||||
| HGNC Symbol | Ensembl Gene ID | Amplification | Deletion | Amplification | Deletion |
| FNDC5 | ENSG00000160097 | 0.00 | 0.00 | 0 | 0 |
| CILP2 | ENSG00000160161 | 0.00 | 0.00 | 0 | 0 |
| TFF3 | ENSG00000160180 | 0.00 | 0.00 | 0 | 0 |
| TFF2 | ENSG00000160181 | 0.00 | 0.00 | 0 | 0 |
| TFF1 | ENSG00000160182 | 0.00 | 0.00 | 0 | 0 |
| TMPRSS3 | ENSG00000160183 | 0.00 | 0.16 | 0 | 1 |
| PDXK | ENSG00000160209 | 0.00 | 0.18 | 0 | 1 |
| CSTB | ENSG00000160213 | 0.12 | 0.18 | 1 | 1 |
| AIRE | ENSG00000160224 | 0.00 | 0.00 | 0 | 0 |
| S100B | ENSG00000160307 | 0.00 | 0.00 | 0 | 0 |
| SLC2A6 | ENSG00000160326 | 0.00 | 0.25 | 0 | 1 |
| FCN2 | ENSG00000160339 | 0.00 | 0.00 | 0 | 0 |
| LCN1 | ENSG00000160349 | 0.00 | 0.00 | 0 | 0 |
| HIPK4 | ENSG00000160396 | 0.00 | 0.00 | 0 | 0 |
| TOR2A | ENSG00000160404 | 0.00 | 0.11 | 0 | 1 |
| MPZL3 | ENSG00000160588 | 0.00 | 0.64 | 0 | 3 |
| PCSK7 | ENSG00000160613 | 0.00 | 1.07 | 0 | 5 |
| CXCR5 | ENSG00000160683 | 0.00 | 0.33 | 0 | 2 |
| IL6R | ENSG00000160712 | 0.22 | 0.00 | 1 | 0 |
| CHRNB2 | ENSG00000160716 | 0.22 | 0.00 | 1 | 0 |
|
Showing page 78 |
first page | previous page | next page | last page |
Copyright © 2020 University of Pennsylvania. All Rights Reserved.